Format

Send to

Choose Destination
J Neurosci Rural Pract. 2019 Jan-Mar;10(1):39-47. doi: 10.4103/jnrp.jnrp_210_18.

Economic Cost of Schizophrenia in a Nigerian Teaching Hospital.

Author information

1
Department of Mental Health, College of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
2
Department of Mental Health, Obafemi Awolowo University Teaching Hospitals Complex, Ile-Ife, Nigeria.

Abstract

Objective:

This study evaluated the economic cost of schizophrenia in Nigerian patients and identified factors that influence cost.

Methods:

A total of 100 participants with schizophrenia were assessed using the modified economic cost questionnaire, the mini-international neuropsychiatric interview, the positive and negative syndrome scale, the Liverpool University Neuroleptic side-effect rating scale, and the global assessment of functioning scale. Associations between sociodemographic characteristics, illness-related variables and direct, indirect, and total costs of schizophrenia were assessed.

Results:

The average annual total, direct, and indirect costs of the treatment were $818.48, $349.59, and $468.89, respectively, per patient. The direct cost constituted 42.7%, while the indirect cost was 57.3% of the total costs of treatment. Hospitalization was the leading contributor to the direct cost, while productivity loss was a major component of the indirect cost.

Conclusion:

Schizophrenia is an expensive disease in Nigeria, measures to reduce hospitalization could significantly reduce the cost of illness to the patient and their relatives.

KEYWORDS:

Cost of illness; direct cost; economic burden; indirect cost; productivity loss; total cost

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center